Literature DB >> 10488211

Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.

R Ghozzi1, P Morand, A Ferroni, J L Beretti, E Bingen, C Segonds, M O Husson, D Izard, P Berche, J L Gaillard.   

Abstract

We used capillary electrophoresis-single-strand conformation polymorphism (CE-SSCP) analysis of PCR-amplified 16S rRNA gene fragments for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli isolated from patients with cystic fibrosis (CF). Target sequences were amplified by using forward and reverse primers labeled with various fluorescent dyes. The labeled PCR products were denatured by heating and separated by capillary gel electrophoresis with an automated DNA sequencer. Data were analyzed with GeneScan 672 software. This program made it possible to control lane-to-lane variability by standardizing the peak positions relative to internal DNA size markers. Thirty-four reference strains belonging to the genera Pseudomonas, Brevundimonas, Burkholderia, Comamonas, Ralstonia, Stenotrophomonas, and Alcaligenes were tested with primer sets spanning 16S rRNA gene regions with various degrees of polymorphism. The best results were obtained with the primer set P11P-P13P, which spans a moderately polymorphic region (Escherichia coli 16S rRNA positions 1173 to 1389 [M. N. Widjojoatmodjo, A. C. Fluit, and J. Verhoef, J. Clin. Microbiol. 32:3002-3007, 1994]). This primer set differentiated the main CF pathogens from closely related species but did not distinguish P. aeruginosa from Pseudomonas alcaligenes-Pseudomonas pseudoalcaligenes and Alcaligenes xylosoxidans from Alcaligenes denitrificans. Two hundred seven CF clinical isolates (153 of P. aeruginosa, 26 of Stenotrophomonas maltophilia, 15 of Burkholderia spp., and 13 of A. xylosoxidans) were tested with P11P-P13P. The CE-SSCP patterns obtained were identical to those for the corresponding reference strains. Fluorescence-based CE-SSCP analysis is simple to use, gives highly reproducible results, and makes it possible to analyze a large number of strains. This approach is suited for the rapid identification of the main gram-negative nonfermenting bacilli encountered in CF.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488211      PMCID: PMC85573          DOI: 10.1128/JCM.37.10.3374-3379.1999

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa.

Authors:  E Kerem; M Corey; R Gold; H Levison
Journal:  J Pediatr       Date:  1990-05       Impact factor: 4.406

2.  Analysis of single-strand conformation polymorphisms by capillary electrophoresis with laser induced fluorescence detection.

Authors:  H Arakawa; A Tsuji; M Maeda; M Kamahori; H Kambara
Journal:  J Pharm Biomed Anal       Date:  1997-06       Impact factor: 3.935

3.  Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  M Fegan; P Francis; A C Hayward; G H Davis; J A Fuerst
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia.

Authors:  C Lewin; C Doherty; J Govan
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

5.  Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.

Authors:  D L Smith; L B Gumery; E G Smith; D E Stableforth; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

Review 6.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

7.  Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.

Authors:  R E Hancock; L M Mutharia; L Chan; R P Darveau; D P Speert; G B Pier
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

Authors:  J J LiPuma; S E Dasen; D W Nielson; R C Stern; T L Stull
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

9.  Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition.

Authors:  M A Luzar; M J Thomassen; T C Montie
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

10.  Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years.

Authors:  V L Hudson; C L Wielinski; W E Regelmann
Journal:  J Pediatr       Date:  1993-06       Impact factor: 4.406

View more
  12 in total

1.  Combined SSCP/duplex analysis by capillary electrophoresis for more efficient mutation detection.

Authors:  P Kozlowski; W J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

2.  Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center.

Authors:  Agnes Ferroni; Isabelle Sermet-Gaudelus; Eric Abachin; Gilles Quesne; Gerard Lenoir; Patrick Berche; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

3.  Bacterial community dynamics during production of registered designation of origin Salers cheese as evaluated by 16S rRNA gene single-strand conformation polymorphism analysis.

Authors:  Frédérique Duthoit; Jean-Jacques Godon; Marie-Christine Montel
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

4.  Raw cow milk bacterial population shifts attributable to refrigeration.

Authors:  Véronique Lafarge; Jean-Claude Ogier; Victoria Girard; Véronique Maladen; Jean-Yves Leveau; Alexandra Gruss; Agnès Delacroix-Buchet
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

5.  Blinded study determination of high sensitivity and specificity microchip electrophoresis-SSCP/HA to detect mutations in the p53 gene.

Authors:  Christa N Hestekin; Jennifer S Lin; Lionel Senderowicz; John P Jakupciak; Catherine O'Connell; Alfred Rademaker; Annelise E Barron
Journal:  Electrophoresis       Date:  2011-10-17       Impact factor: 3.535

6.  A novel eukaryote-made thermostable DNA polymerase which is free from bacterial DNA contamination.

Authors:  Hideki Niimi; Masashi Mori; Homare Tabata; Hiroshi Minami; Tomohiro Ueno; Shirou Hayashi; Isao Kitajima
Journal:  J Clin Microbiol       Date:  2011-07-20       Impact factor: 5.948

7.  Identification of Mycobacterium species by multiple-fluorescence PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene.

Authors:  L M Gillman; J Gunton; C Y Turenne; J Wolfe; A M Kabani
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

8.  Real-time identification of Pseudomonas aeruginosa direct from clinical samples using a rapid extraction method and polymerase chain reaction (PCR).

Authors:  R I Jaffe; J D Lane; C W Bates
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

9.  Capillary electrophoresis-single strand conformation polymorphism for the detection of multiple mutations leading to tuberculosis drug resistance.

Authors:  Sowmya Krothapalli; Michael K May; Christa N Hestekin
Journal:  J Microbiol Methods       Date:  2012-08-03       Impact factor: 2.363

10.  Cryptococcus gattii in AIDS patients, southern California.

Authors:  Sudha Chaturvedi; Madhu Dyavaiah; Robert A Larsen; Vishnu Chaturvedi
Journal:  Emerg Infect Dis       Date:  2005-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.